Decagon vs Insilico Medicine

Decagon — Application · Private · $4.5B valuation · 4 of 4 figures sourced  |  Insilico Medicine — Application · Public · $4.3B mkt cap · 5 of 5 figures sourced

Relationship

Assembled from the recorded fields for this pair, not hand-checked. The comparison below is read from each company’s own profile.

Aligned comparison

FieldDecagonInsilico Medicine
Size$4.5B valuation$4.3B mkt cap different basis
Employees300333 Insilico Medicine has 11% more
Founded20232014 9 yrs earlier
StatusPrivatePublic
CategoryApplicationApplication match
Stack layerAI agent, Agent platform, ApplicationApplication, Hardware, Platform
HeadquartersSan Francisco, USAHong Kong

Capability overlap

Shared · 4

Agent orchestrationData analysisEvaluation and observabilitySummarization

Not verified for Insilico Medicine · 3

Customer supportEmail assistanceVoice agent

Recorded for Decagon. Insilico Medicine’s product records say nothing either way — a missing record is not a missing capability.

Not verified for Decagon · 4

Drug discoveryModel trainingKnowledge retrievalText generation

Recorded for Insilico Medicine. Decagon’s product records say nothing either way — a missing record is not a missing capability.

Products, side by side

Algorithmic pairing — assembled from recorded fields, not hand-checked

Decagon

Application

ExperimentsApplication

A/B-testing suite for AI support agents: structured experiments (tone, logic, flows) against live traffic with control groups, statistical-significance testing and gradual rollout.

Insights & ReportingApplication

Dashboards and natural-language querying ('Ask AI') over support data: CSAT/deflection performance tracking, heatmaps, customer-journey visualization and knowledge-base performance.

SuggestionsApplication

Analyzes support conversations to detect gaps in a company's help center and auto-generates draft articles, ranked by impact, with monthly updates.

Testing & QAApplication

Integrated testing suite (internally called 'Simulations') that validates AI-agent behavior across channels before production deployment.

WatchtowerApplication

Always-on monitoring and QA for AI and human agent interactions against custom quality criteria.

Insilico Medicine

Application

Science42: DORAApplication

AI research writing assistant that drafts structured, cited papers, reviews, grant proposals and abstracts against biomedical databases such as PubMed and bioRxiv.

inClinicoApplication

Multimodal AI platform that forecasts the probability of success of individual clinical trials and scores alternative trial designs before implementation.

No counterpart

Decagon sells these in a stack layer with no product recorded for Insilico Medicine yet — nothing on the other side to compare them against.

AI agent

DecagonAI agent

Builds and runs customer-support agents that resolve enquiries over chat, email and voice.

Decagon ChatAI agent

Decagon's chat channel — an AI agent that handles live customer conversations in a web or in-app chat surface.

Decagon EmailAI agent

Decagon's email channel — agents that read and answer customer email threads rather than routing them to a queue.

Decagon VoiceAI agent

Decagon's voice channel — an AI agent that answers customer phone calls in place of a hold queue.

Agent platform

Agent Operating ProceduresAgent platform

Decagon's authoring layer for the rules an AI support agent follows, so non-engineering teams can build, iterate on and scale agents.

DuetAgent platform

An AI partner built into Decagon that helps teams build and improve support agents — distilling best practices from hundreds of Decagon deployments into guidance for the builder, and auto-tuning the agent via "Duet Autopilot," which improves it with every conversation it handles.

Insilico Medicine sells these in a stack layer with no product recorded for Decagon yet — nothing on the other side to compare them against.

Platform

Biology42: Generative BiologicsPlatform

AI platform for de novo design and multi-property optimization of peptides, nanobodies and antibodies against specified targets and epitopes.

Chemistry42Platform

Generative small-molecule design platform combining de novo generation with physics-based methods, retrosynthesis, ADMET profiling and custom model training.

MMAI GymPlatform

Foundation-model training and benchmarking platform that fine-tunes a customer's own LLM on Insilico's proprietary pharma reasoning datasets and validates results in its automation lab.

PandaOmicsPlatform

AI platform for therapeutic target identification, biomarker discovery, indication prioritization and drug repurposing over a multi-omics knowledge base.

Pharma.AIPlatform

End-to-end generative-AI platform spanning target discovery, molecular design and clinical-trial risk assessment for pharmaceutical research.

Hardware

PandaOmics BoxHardware

On-premise AI appliance running PandaOmics target and biomarker discovery locally with no external data transmission, sold in Server and Desktop editions.